2seventy bio Inc’s filing revealed that its Director Casdin Capital, LLC acquired Company’s shares for reported $0.2 million on Mar 26 ’24. In the deal valued at $5.10 per share,40,000 shares were bought. As a result of this transaction, Casdin Capital, LLC now holds 2,000,000 shares worth roughly $10.08 million.
Then, Casdin Capital, LLC bought 330,000 shares, generating $1,673,991 in total proceeds. Upon buying the shares at $5.07, the Director now owns 1,960,000 shares.
Before that, Casdin Capital, LLC bought 147,377 shares. 2seventy bio Inc shares valued at $754,069 were divested by the Director at a price of $5.12 per share. As a result of the transaction, Casdin Capital, LLC now holds 1,630,000 shares, worth roughly $8.22 million.
Leerink Partners upgraded its 2seventy bio Inc [TSVT] rating to an Outperform from a a Market perform in a research note published on January 31, 2024; the price target was increased to $18 from $5. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in late January from “an Outperform” to “a Market perform”. Leerink Partners also remained covering TSVT and has decreased its forecast on October 30, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. Citigroup started covering the stock on October 12, 2023. It rated TSVT as “a Buy”.
Price Performance Review of TSVT
On Friday, 2seventy bio Inc [NASDAQ:TSVT] saw its stock fall -8.70% to $5.04. Over the last five days, the stock has gained 2.44%. 2seventy bio Inc shares have risen nearly 18.03% since the year began. Nevertheless, the stocks have fallen -43.18% over the past one year. While a 52-week high of $12.69 was reached on 02/20/24, a 52-week low of $1.53 was recorded on 01/26/24. SMA at 50 days reached $5.25, while 200 days put it at $4.88. A total of 0.8 million shares were traded, compared to the trading of 0.71 million shares in the previous session.
Levels Of Support And Resistance For TSVT Stock
The 24-hour chart illustrates a support level at 4.84, which if violated will result in even more drops to 4.63. On the upside, there is a resistance level at 5.37. A further resistance level may holdings at 5.70. The Relative Strength Index (RSI) on the 14-day chart is 49.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.53%. Stochastics %K at 43.76% indicates the stock is a holding.
